-- ヒムズ＆ハーズ・ヘルス（HIMS）の株価は、米国の保健当局高官が特定のペプチドに対する規制緩和計画を示唆したことを受け、木曜日の取引開始前に7%以上上昇した。 ロバート・ケネディ・ジュニア米保健福祉長官は、Xへの投稿で、米食品医薬品局（FDA）が12種類のペプチドをカテゴリー2リストから削除し、7月に諮問委員会による審査を受ける予定だと述べた。 ケネディ長官は、この変更により、ペプチドベースの治療薬への規制されたアクセスが拡大し、闇市場からの需要が減少する可能性があると述べた。
Price: $26.16, Change: $+1.87, Percent Change: +7.70%
Sunshine Metals (ASX:SHN) completed resource definition drilling at the Liontown gold panel, a gold-dominant deposit which is part of its Ravenswood consolidated project in Queensland, in late March, according to a Monday Australian bourse filing.The mining study and mineral resource for the Liontown project will be further updated and upgraded in May to incorporate results from the grade control drilling program.
Wanxiang Qianchao (SHE:000559) posted first-quarter attributable net profit of 246.8 million yuan, down 16% from 293.3 million yuan the previous year.Earnings per share declined to 0.074 yuan from 0.089 yuan, according to a weekend filing with the Shenzhen bourse.Operating revenue slipped 20% year over year to 2.80 billion yuan from 3.50 billion yuan.Shares of the auto parts manufacturer declined 3% in recent trade.
Eng Kah (KLSE:ENGKAH) is seeking its shareholders' approval to renew share buyback authority to purchase up to 10% of the issued shares in the company's upcoming annual general meeting, according to a Friday Malaysian bourse filing.Shares gained about 3% in Monday's afternoon trade.The manufacturer of cosmetics, personal care, household, and perfume products will share a detailed statement of the repurchase plan with shareholders in due time.